Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 3/2014

01.09.2014 | original report

Clinicopathological profile of bilateral breast cancer at a tertiary cancer center in South India

verfasst von: K. C. Lakshmaiah, MD, DM, Umesh Das, MD, K. Govind Babu, MD, DM, T. M. Suresh, MD, DM, D. Lokanatha, MD, DM, Linu A. Jacob, MD, DM, Suresh Babu, MD, DM, Prof. G. Mukherjee, Prof. M. Vijayakumar

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Bilateral breast cancer (BBC) is an unusual clinical entity. Unlike unilateral breast cancer, there is fewer data regarding clinicopathological aspects and treatment guidelines in BBC. The present study was carried out at a tertiary oncology center in South India to analyze the clinicopathological profile of patients diagnosed with BBC.

Methods

This was a retrospective observational study of patients diagnosed with BBC in the department of medical oncology from August 2012 to July 2013.

Results

Out of a total of 300 breast cancer patients during a 1-year period, 15 had BBC. Synchronous and metachronous breast cancers were seen in six and nine patients, respectively. The median age at presentation for BBC was 40 years. Family history of breast cancer was present only in two cases. The median age of menarche and first child birth was 13 and 22 years, respectively. History of breast feeding was positive in all except one who was nulliparous. Out of the 15 patients, 11 were premenopausal and 4 postmenopausal. Contralateral breast cancer was detected mammographically in 4 patients and by clinical examination in 11. Out of 30 tumors, all were invasive ductal carcinomas (IDC). Nine patients had bilateral mastectomy, and five had unilateral mastectomy. Out of 30 tumors, 14 were triple negative, 9 estrogen receptor (ER)/progesterone (PR) positive, and 7 Her2neu positive. Neoadjuvant chemotherapy (NACT) was given in four synchronous and three metachronous breast cancer cases for contralateral breast cancer. All patients received chemotherapy during the course in the form of either adjuvant or palliative chemotherapy.

Conclusions

BBC is an uncommon clinical entity. For women with younger premenopausal age, the incidence of BBC is higher compared with older women. As the prognosis of BBC is poor, it is crucial to be aware of this entity, and every patient with breast cancer should be regularly followed up. These patients require individualized treatment planning based on the tumor factors and treatment factors of the primary lesion.
Literatur
1.
Zurück zum Zitat Chaudary MA, Millis RR, Hoskins EO, et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg. 1984;71:711–4.PubMedCrossRef Chaudary MA, Millis RR, Hoskins EO, et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg. 1984;71:711–4.PubMedCrossRef
2.
Zurück zum Zitat El Hanchi Z, Berrada R, Fadli A, et al. Bilateral breast cancer: incidence and risk factors. Gynecol Obstet Fertil. 2004;32:128–34. In French.PubMedCrossRef El Hanchi Z, Berrada R, Fadli A, et al. Bilateral breast cancer: incidence and risk factors. Gynecol Obstet Fertil. 2004;32:128–34. In French.PubMedCrossRef
3.
Zurück zum Zitat Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer. 2000;88:2739–50.PubMedCrossRef Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer. 2000;88:2739–50.PubMedCrossRef
4.
Zurück zum Zitat Al-Jurf AS, Jochimsen PR, Urdaneta LF, Scott DH. Factors influencing survival in bilateral breast cancer. J Surg Oncol. 1981;16:343–8.PubMedCrossRef Al-Jurf AS, Jochimsen PR, Urdaneta LF, Scott DH. Factors influencing survival in bilateral breast cancer. J Surg Oncol. 1981;16:343–8.PubMedCrossRef
5.
6.
Zurück zum Zitat Chen Y, Thompson W, Semenciw R, et al. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:855–61. Chen Y, Thompson W, Semenciw R, et al. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:855–61.
7.
Zurück zum Zitat Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG. Second primary cancers of the breast: incidence and risk factors. Br J Cancer. 1984;49:79–85.PubMedCrossRefPubMedCentral Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG. Second primary cancers of the breast: incidence and risk factors. Br J Cancer. 1984;49:79–85.PubMedCrossRefPubMedCentral
8.
Zurück zum Zitat Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH. Synchronous, bilateral breast cancer: prognostic value and incidence. Breast. 2003;12(2):83–8.PubMedCrossRef Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH. Synchronous, bilateral breast cancer: prognostic value and incidence. Breast. 2003;12(2):83–8.PubMedCrossRef
9.
Zurück zum Zitat Robinson E, Rennert G, Rennert HS, Neugut AI. Survival of first and second primary breast cancer. Cancer. 1993;71:172–6. Robinson E, Rennert G, Rennert HS, Neugut AI. Survival of first and second primary breast cancer. Cancer. 1993;71:172–6.
10.
Zurück zum Zitat Haagensen CD. The natural history of breast cancer. In: Diseases of the breast. 2nd ed. Philadelphia: Saunders; 1971. S. 380–465. Haagensen CD. The natural history of breast cancer. In: Diseases of the breast. 2nd ed. Philadelphia: Saunders; 1971. S. 380–465.
11.
Zurück zum Zitat MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, et al. Age at first birth and breast cancer risk. Bull World Health Organ. 1970;43(2):209–21.PubMedPubMedCentral MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, et al. Age at first birth and breast cancer risk. Bull World Health Organ. 1970;43(2):209–21.PubMedPubMedCentral
12.
Zurück zum Zitat Bernstein JL, Thompson WD, Risch N, Holford TR. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol. 1992;136(8):925–36.PubMed Bernstein JL, Thompson WD, Risch N, Holford TR. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol. 1992;136(8):925–36.PubMed
13.
Zurück zum Zitat Horn PL, Thompson D. Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol. 1988;128:309–23.PubMed Horn PL, Thompson D. Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol. 1988;128:309–23.PubMed
14.
Zurück zum Zitat Khairy GA, Guraya SY, Ahmed ME, Ahmed MA. Bilateral breast cancer. Incidence, diagnosis and histological patterns. Saudi Med J. 2005;26(4):612–5.PubMed Khairy GA, Guraya SY, Ahmed ME, Ahmed MA. Bilateral breast cancer. Incidence, diagnosis and histological patterns. Saudi Med J. 2005;26(4):612–5.PubMed
15.
Zurück zum Zitat Slack NH, Bross ID, Nemoto T, Fisher B. Experience with bilateral primary carcinoma of the breast. Surg Gynecol Obstet. 1973;136(3):433–40.PubMed Slack NH, Bross ID, Nemoto T, Fisher B. Experience with bilateral primary carcinoma of the breast. Surg Gynecol Obstet. 1973;136(3):433–40.PubMed
16.
Zurück zum Zitat Hankey BF, Curtis RE, Naughton MD, Boice JD, Jr., Flannery JT. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst. 1983;70(5):797–804.PubMed Hankey BF, Curtis RE, Naughton MD, Boice JD, Jr., Flannery JT. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst. 1983;70(5):797–804.PubMed
18.
Zurück zum Zitat Robbins GF, Berg JW. Bilateral primary breast cancer, a prospective clinicopathological study. Cancer. 1964;17:1501–27.PubMedCrossRef Robbins GF, Berg JW. Bilateral primary breast cancer, a prospective clinicopathological study. Cancer. 1964;17:1501–27.PubMedCrossRef
19.
Zurück zum Zitat Suryanarayana Deo V, Shridhar D, Shukla NK, Kumar S, Purkayastha J, Raina V, Rath GK. Clinical profile and management of bilateral breast cancer. Breast Cancer Res. 2005;7(Suppl. 1):P6. doi:10.1186/bcr1240. Suryanarayana Deo V, Shridhar D, Shukla NK, Kumar S, Purkayastha J, Raina V, Rath GK. Clinical profile and management of bilateral breast cancer. Breast Cancer Res. 2005;7(Suppl. 1):P6. doi:10.1186/bcr1240.
20.
Zurück zum Zitat Bernstein JL, Lapinski RH, Thakore SS, Doucette JT, Thompson WD. The descriptive epidemiology of second primary breast cancer. Epidemiology. 2003;14(5):552–8.PubMedCrossRef Bernstein JL, Lapinski RH, Thakore SS, Doucette JT, Thompson WD. The descriptive epidemiology of second primary breast cancer. Epidemiology. 2003;14(5):552–8.PubMedCrossRef
21.
Zurück zum Zitat Li CI, Malone KE, Porter PL, Daling JR. Epidedmiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer. 2003;89(3):513–8.PubMedCrossRefPubMedCentral Li CI, Malone KE, Porter PL, Daling JR. Epidedmiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer. 2003;89(3):513–8.PubMedCrossRefPubMedCentral
22.
Zurück zum Zitat Gong SJ, Rha SY, Jeung HC, Roh JK, Yang WI, Chung HC. Bilateral breast cancer: differential diagnosis using histological and biological parameters. Jpn J Clin Oncol. 2007;37:487–92.PubMedCrossRef Gong SJ, Rha SY, Jeung HC, Roh JK, Yang WI, Chung HC. Bilateral breast cancer: differential diagnosis using histological and biological parameters. Jpn J Clin Oncol. 2007;37:487–92.PubMedCrossRef
23.
Zurück zum Zitat Henderson IC, Patek AJ. The relationship between prognostic and predictive factors in management of breast cancer. Breast Cancer Res Treat. 1998;52(1–3):261–88.PubMedCrossRef Henderson IC, Patek AJ. The relationship between prognostic and predictive factors in management of breast cancer. Breast Cancer Res Treat. 1998;52(1–3):261–88.PubMedCrossRef
24.
Zurück zum Zitat Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology and End Results database. Breast Cancer Res Treat. 2002;76(1):27–36.PubMedCrossRef Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology and End Results database. Breast Cancer Res Treat. 2002;76(1):27–36.PubMedCrossRef
25.
Zurück zum Zitat Horn PL, Thompson WD. Risk of contralateral breast cancer. Association with histologic, clinical, and therapeutic factors. Cancer. 1988;62(2):412–4.PubMedCrossRef Horn PL, Thompson WD. Risk of contralateral breast cancer. Association with histologic, clinical, and therapeutic factors. Cancer. 1988;62(2):412–4.PubMedCrossRef
26.
Zurück zum Zitat Mariani L, Coradini D, Biganzoli E, Boracchi P, Marubini E, Pilotti S, Salvadori B, Silvestrini R, Veronesi U, Zucali R, Rilke F. Prognosic factors for metachronous contralateral breast cancer: a comparison of linear Cox regression model and its artificial neural network expression. Breast Cancer Res Treat. 1997;44(2):167–78.PubMedCrossRef Mariani L, Coradini D, Biganzoli E, Boracchi P, Marubini E, Pilotti S, Salvadori B, Silvestrini R, Veronesi U, Zucali R, Rilke F. Prognosic factors for metachronous contralateral breast cancer: a comparison of linear Cox regression model and its artificial neural network expression. Breast Cancer Res Treat. 1997;44(2):167–78.PubMedCrossRef
27.
Zurück zum Zitat Safal M, Lower EE, Hasselgren PO, Hungness ES, Gazder P, Aron B, Shaughnessy EA, Yassin R. Bilateral synchronous breast cancer and HER-2/neu overexpression. Breast Cancer Res Treat. 2002;72(3):195–201.PubMedCrossRef Safal M, Lower EE, Hasselgren PO, Hungness ES, Gazder P, Aron B, Shaughnessy EA, Yassin R. Bilateral synchronous breast cancer and HER-2/neu overexpression. Breast Cancer Res Treat. 2002;72(3):195–201.PubMedCrossRef
28.
Zurück zum Zitat van Agthoven T, Timmermans M, Dorssers LC, Henzen-Logmans SC. Expression of estrogen, progesterone and epidermal growth factor receptor in primary and metastatic breast cancer. Int J Cancer. 1995;63:790–3.PubMedCrossRef van Agthoven T, Timmermans M, Dorssers LC, Henzen-Logmans SC. Expression of estrogen, progesterone and epidermal growth factor receptor in primary and metastatic breast cancer. Int J Cancer. 1995;63:790–3.PubMedCrossRef
Metadaten
Titel
Clinicopathological profile of bilateral breast cancer at a tertiary cancer center in South India
verfasst von
K. C. Lakshmaiah, MD, DM
Umesh Das, MD
K. Govind Babu, MD, DM
T. M. Suresh, MD, DM
D. Lokanatha, MD, DM
Linu A. Jacob, MD, DM
Suresh Babu, MD, DM
Prof. G. Mukherjee
Prof. M. Vijayakumar
Publikationsdatum
01.09.2014
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2014
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-014-0153-9

Weitere Artikel der Ausgabe 3/2014

memo - Magazine of European Medical Oncology 3/2014 Zur Ausgabe